The correlation between high-sensitivity c-reactive protein, matrix metallopeptidase 9, and traditional chinese medicine syndrome in patients with hypertension

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Wu, Aiming ^a   Zhang, Dongmei ^a   Gao, Yonghong ^a   Lou, Lixia ^a   Zhu, Haiyan ^a   Chai, Limin ^a   Lv, Xiying ^a   Sun, Yikun ^a   Zhu, Lingqun ^a   Wang, Shuoren ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B;

ADULT; ARTICLE; CHINESE MEDICINE; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYNDROME; TRADITIONAL CHINESE MEDICINE SYNDROME; TRADITIONAL MEDICINE;

EID: 84876514480     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/780937     Document Type: Article

References (47)

1. Sliwa K., Stewart S., Gersh B. J., Hypertension: a global perspective. Circulation 2011 123 24 2892 2896 2-s2.0-79959509371 10.1161/CIRCULATIONAHA.110. 992362
2. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. The Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
3. Pedrinelli R., Ballo P., Fiorentini C., Denti S., Galderisi M., Ganau A., Germano G., Innelli P., Paini A., Perlini S., Salvetti M., Zaca V., Hypertension and acute myocardial infarction: an overview. Journal of Cardiovascular Medicine 2012 13 3 194 202 10.2459/JCM.0b013e3283511ee2
4. Herlitz J., Bång A., Karlson B. W., Five-year prognosis after acute myocardial infarction in relation to a history of hypertension. American Journal of Hypertension 1996 9 1 70 76 2-s2.0-0342502238 10.1016/0895-7061(95) 00302-9 (Pubitemid 26060111)
5. Capone C., Faraco G., Peterson J. R., Coleman C., Anrather J., Milner T. A., Pickel V. M., Davisson R. L., Iadecola C., Central cardiovascular circuits contribute to the neurovascular dysfunction in angiotensin II hypertension. Journal of Neuroscience 2012 32 14 4878 4886 10.1523/JNEUROSCI.6262-11.2012
6. Jones D. W., Hall J. E., Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure and evidence from new hypertension trials. Hypertension 2004 43 1 1 3 2-s2.0-0347418917 10.1161/01.HYP.0000110061.06674.ca (Pubitemid 38031902)
7. Wang J., Xiong X., Outcome measures of Chinese herbal medicine for hypertension: an overview of systematic reviews. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 697237 10.1155/2012/697237
8. Wang J., Yao K., Yang X., Liu W., Feng B., Ma J., Du X., Wang P., Xiong X., Chinese patent medicine liu wei di huang wan combined with antihypertensive drugs, a new integrative medicine therapy, for the treatment of essential hypertension: a systematic review of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine 2012 2012 7 714805 10.1155/2012/714805
9. Zhao H., Chen J., Hou N., Zhang P., Wang Y., Han J., Hou Q., Qi Q., Wang W., Discovery of diagnosis pattern of coronary heart disease with qi deficiency syndrome by the T-test-based adaboost algorithm. Evidence-Based Complementary and Alternative Medicine 2011 2011 7 408650 10.1155/2011/408650
10. Lu P., Chen J., Zhao H., Gao Y., Luo L., Zuo X., Shi Q., Yang Y., Yi J., Wang W., In silico syndrome prediction for coronary artery disease in traditional chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 142584 10.1155/2012/142584
11. Zhao H., Chen J., Shi Q., Ma X., Yang Y., Luo L., Guo S., Wang Y., Han J., Wang W., Metabolomics-based study of clinical and animal plasma samples in coronary heart disease with blood stasis syndrome. Evidence-Based Complementary and Alternative Medicine 2012 2012 638723 10.1155/2012/638723
12. Shi Q., Zhao H., Chen J., Ma X., Yang Y., Zheng C., Wang W., Study on TCM syndrome identification modes of coronary heart disease based on data mining. Evidence-Based Complementary and Alternative Medicine 2012 2012 697028 10.1155/2012/697028
13. Chen R., Liang F. X., Huang Y. X., Li B., Study on relationship between TCM Syndrome types (Xin-qi and Xin-yang deficiency) and contents of cytokines (tumor necrosis factor-alpha and interleukins) in patients with congestive heart failure. Zhongguo Zhong Xi Yi Jie He Za Zhi 2004 24 10 876 878 2-s2.0-16644382452
14. Cao Y. X., Dong J. C., Du Y. J., Biomarkers and inflammatory characteristics for microcosmic syndrome differentiation of cold-phlegm syndrome and heat-phlegm syndrome in patients with bronchial asthma. Zhongguo Zhong Xi Yi Jie He Za Zhi 2010 30 8 828 832
15. Wu A. M., Zhang D. M., Wang S. R., Sun Y. K., Niu F. L., Lv X. Y., Sou H. L., Changes of serum matrix-metalloproteinase 9 levels and analysis of its risk factors in patients with hypertensive complicated cerebral infarction. Journal of Clinical Neurology 2008 21 6 444 445
16. Qu J., Zou Y. H., Zhang D. M., Wu A. M., Sun Y. K., Lv X. Y., Related laboratory indicators of the poison damage brain network in Acute stage of stroke. Beijing Journal of Traditional Chinese Medicine 2010 29 3 163 166
17. Suo H. L., Wang S. R., Wu A. M., Zhang D. M., Shi F. Q., Risk stratification of EH and correlation between TCM syndromes of EH and high-sensitivity C-reactive protein in clinic. Journal of Beijing University of Traditional Chinese Medicine 2009 32 4 265 269
18. Zhao J., Wu A. M., Zhang Y., Ren Y., Zhou Y. H., Correlation between TCM syndromes and high-sensitivity C-reactive protein of stroke. Journal of Beijing University of Traditional Chinese Medicine 2009 16 2 13 16
19. Sou H. L., Wang S. R., Wu A. M., Lv X. Y., Sun Y. K., Zhang D. M., Shi F. Q., Aggregation function of platelets in the blood inflammatory state of patients with essential hypertension and the TCM syndrome research. Beijing Journal of Traditional Chinese Medicine 2009 28 3 175 178
20. Assuncao L. G., Eloi-Santos S. M., Peixoto S. V., High sensitivity C-reactive protein distribution in the elderly: the Bambui Cohort Study, Brazil. Brazilian Journal of Medical and Biological Research 2012 45 12 1284 1286
21. Ferri C., Croce G., Cofini V., De Berardinis G., Grassi D., Casale R., Properzi G., Desideri G., C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis. Current Pharmaceutical Design 2007 13 16 1631 1645 2-s2.0-34250885140 10.2174/138161207780831301 (Pubitemid 46979719)
22. Rost N. S., Wolf P. A., Kase C. S., Kelly-Hayes M., Silbershatz H., Massaro J. M., D'Agostino R. B., Franzblau C., Wilson P. W. F., Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke 2001 32 11 2575 2579 2-s2.0-0035170373 (Pubitemid 33055308)
23. Schlager O., Exner M., Mlekusch W., Sabeti S., Amighi J., Dick P., Wagner O., Koppensteiner R., Minar E., Schillinger M., C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke 2007 38 4 1263 1268 2-s2.0-34247873116 10.1161/01.STR.0000259890.18354.d2 (Pubitemid 351664261)
24. Shafi Dar M., Pandith A. A., Sameer A. S., Sultan M., Yousuf A., Mudassar S., Hs-CRP: a potential marker for hypertension in Kashmiri population. Indian Journal of Clinical Biochemistry 2010 25 2 208 212 2-s2.0-77955441598 10.1007/s12291-010-0037-7
25. Li J. J., Fang C. H., C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Medical Hypotheses 2004 62 4 499 506 2-s2.0-1842505521 10.1016/j.mehy.2003.12.014 (Pubitemid 38453349)
26. Di Napoli M., Elkind M. S., Godoy D. A., Singh P., Papa F., Popa-Wagner A., Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Review of Cardiovascular Therapy 2011 9 12 1565 1584 10.1586/erc.11.159
27. Pepys M. B., Hirschfield G. M., C-reactive protein and its role in the pathogenesis of myocardial infarction. Italian Heart Journal 2001 2 11 804 806 2-s2.0-0035673433 (Pubitemid 34041368)
28. Nakou E. S., Liberopoulos E. N., Milionis H. J., Elisaf M. S., The role of C-reactive protein in atherosclerotic cardiovascular disease: an overview. Current Vascular Pharmacology 2008 6 4 258 270 2-s2.0-55449120556 10.2174/157016108785909733
29. Sternlicht M. D., Werb Z., How matrix metalloproteinases regulate cell behavior. Annual Review of Cell and Developmental Biology 2001 17 463 516 2-s2.0-0035188727 10.1146/annurev.cellbio.17.1.463 (Pubitemid 33096184)
30. Galis Z. S., Sukhova G. K., Lark M. W., Libby P., Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. Journal of Clinical Investigation 1994 94 6 2493 2503 2-s2.0-0028063408 (Pubitemid 24379627)
31. The Hypertension Prevention Guideline Revision Committee of China, The Chinese hypertension clinic guide 2005. Chinese Journal of Hypertension 2005 13 1 37
32. Gao R. L., Acute myocardial infarction diagnosis and treatment guideline. Chinese Journal of Cardiology 2001 29 12 710 725
33. The Fourth Cerebrovascular Disease of the Chinese Medical Association Conference, Various types of cerebrovascular disease diagnostic points. Chinese Journal of Neurology 1996 29 6 379 380
34. The TCM Syndrome Diagnostic efficacy of standard editorial Committee, Criteria of DiagnoSiS and therapeutic Effect of Diseases and Syndromes in Traditional Chinese Medicine (the People's Republic of China TCM Industry Standard ZY/T001.1 001. 9-94) 1994 Beijing, China State Administration of Traditional Chinese Medicine of the People's Republic of China
35. The China Association of Integrative Medicine Professional Committee of Huoxiehuayu, Standard of blood stasis diagnosis. Chinese Journal of Integrated Traditional and Western Medicin 1987 7 3 129
36. Sen Z. Y., Wang W. J., Standard of TCM syndrome differentiation of deficiency. Chinese Journal of Integrated Traditional and Western Medicine 1986 6 10 598
37. Bei Z. P., Diagnosis Standard in 3200 Cases of Medical Disease 1996 Beijing, China Science Press
38. MacMahon S., Alderman M. H., Lindholm L. H., Liu L., Sanchez R. A., Seedat Y. K., Blood-pressure-related disease is a global health priority. The Lancet 2008 371 9623 1480 1482 2-s2.0-43049147142 10.1016/S0140-6736(08)60632-7 (Pubitemid 351626171)
39. Papademetriou V., From hypertension to heart failure. Journal of Clinical Hypertension 2004 6 10, supplement 2 14 17 2-s2.0-21644452255
40. Ernst E., Complementary/alternative medicine for hypertension: a mini-review. Wiener Medizinische Wochenschrift 2005 155 17-18 386 391 2-s2.0-26944475172 10.1007/s10354-005-0205-1 (Pubitemid 41482719)
41. Seo W. K., Seok H. Y., Kim J. H., Park M. H., Yu S. W., Oh K., Koh S. B., Park K. W., C-reactive protein is a predictor of early neurologic deterioration in acute ischemic stroke. Journal of Stroke & Cerebrovascular Diseases 2012 21 3 181 186 10.1016/j.jstrokecerebrovasdis.2010.06.002
42. Di Napoli M., Papa F., Bocola V., C-reactive protein in ischemic stroke an independent prognostic factor. Stroke 2001 32 4 917 924 2-s2.0-0035067998 (Pubitemid 32285161)
43. Huang Y., Jing J., Zhao X. Q., Wang C. X., Wang Y. L., Liu G. F., Wang C. J., Liu L. P., Yang X. M., Jiao Y., Wang L. S., Wang Y. J., Gu W. K., High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese. CNS Neuroscience & Therapeutics 2012 18 3 261 266 10.1111/j.1755-5949.2012.00296.x
44. Laaksonen D. E., Niskanen L., Nyyssönen K., Punnonen K., Tuomainen T. P., Salonen J. T., C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. European Heart Journal 2005 26 17 1783 1789 2-s2.0-24044512353 10.1093/eurheartj/ehi237 (Pubitemid 41219852)
45. den Hertog H. M., Van Rossum J. A., Van Der Worp H. B., Van Gemert H. M. A., De Jonge R., Koudstaal P. J., Dippel D. W. J., C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. Journal of Neurology 2009 256 12 2003 2008 2-s2.0-71849109771 10.1007/s00415-009-5228-x
46. Rybakowski J. K., Matrix metalloproteinase-9 (MMP9)-a mediating enzyme in cardiovascular disease, cancer, and neuropsychiatric disorders. Cardiovascular Psychiatry and Neurology 2009 2009 7 904836 10.1155/2009/904836
47. Kaplan R. C., Smith N. L., Zucker S., Heckbert S. R., Rice K., Psaty B. M., Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 2008 201 1 130 137 2-s2.0-53849138794 10.1016/j.atherosclerosis.2008.01.003